Breaking News

First Opinion is in summer mode (and I don’t mean vacation mode)

August 6, 2023
Editor, First Opinion

Ah, summer — a time for beach vacations, hikes in lush forests, and blockbuster movies. In First Opinion land, that means looking at airlines and the health care system, ticks, and lessons for AI in medicine.

Let's start with the horrifying. This week, Lindsey Ulin writes about a terrifying experience she had on a plane earlier this year. As a physician, when she began experiencing anaphylaxis, she knew she needed epinephrine immediately. But her plane did not come equipped with an epinephrine autoinjector, aka an EpiPen. Since 2016, when there was an EpiPen shortage, the Federal Aviation Administration has issued airlines "emergency" waivers, which allow planes to take off without one onboard. Ulin ended up being lucky — but she says it's far past time for the FAA to require EpiPens on every plane again.

As someone with a pretty intense bug phobia, I am pretty proud of making it through editing Richard S. Ostfeld's delightful essay about being a tick biologist whose body seems to kill ticks. I'm mighty jealous — but it also gives me hope. As he points out, by studying people like him, perhaps researchers will be able to create a tick-busting vaccine one day. Can I sign up for that clinical trial?

Back to health care and airlines: People often say that the medical system needs to take lessons from the airline industry. Given the chaos of air travel this summer, Mary C. Meyer, a frontline physician and director of disaster preparedness for a California health care organization, is flipping that truism.

Plus: "Oppenheimer" has some lessons for AI in medicine. Former Sen. Max Baucus makes the compelling point that advances in Alzheimer's treatment are literally inaccessible for people in rural areas, like his home state of Montana. And more below.

Anaphylaxis is a life-threatening medical emergency and has to be treated with epinephrine, sometimes delivered through an EpiPen, as soon as possible.
JOSEPH PREZIOSO/AFP via Getty Images

I learned the hard way that U.S. airlines are not currently required to have EpiPens

I could have died because my plane did not have an epinephrine autoinjector onboard — and it was completely legal.

By Lindsey Ulin


The airline industry needs some disaster management lessons. Health care can help

As a frontline physician and director of disaster preparedness for a health care organization, I have some tips for airlines.

By Mary C. Meyer


I'm a tick biologist whose body seems to kill off ticks

Maybe my body's defenses against ticks could end up helping create a vaccine for Lyme, anaplasmosis, or babesiosis someday.

By Richard S. Ostfeld



AP

'Oppenheimer' is a must-watch for everyone who works in AI and health care

J. Robert Oppenheimer's story offers particularly salient lessons for health care leaders, entrepreneurs, and policymakers.

By Junaid Nabi


The high out-of-pocket cost of donating a kidney

Donating my kidney added up to $5,000 in expenses that neither insurance nor the hospital could cover.

By Martha Gershun


Former Sen. Max Baucus: Breakthrough Alzheimer's drugs are out of reach for many in rural states like Montana

A Medicare policy may keep crucial new Alzheimer's drugs from helping in rural areas, writes former Sen. Max Baucus.

By Max Baucus


The superbug Staphylcocus epidermidis is shown on an agar plate. More than 3 million Americans develop a drug-resistant infection each year.
WILLIAM WEST/AFP/Getty Images

Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff

Infections play a primary or secondary role in the death of roughly half of patients with some types of cancer.

By Helen W. Boucher and Kevin Outterson


New attacks on the drug industry would have made my breakthrough sickle cell treatment impossible

I fear that as a direct result of two recent policy shifts, success stories like mine will become impossible.

By Ted W. Love


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments